The Dollar Institute for Age Study and also Q Therapies, Inc. announced a contract to collaborate on novel courses to fight Parkinson's disease. The Dollar Institute and also Q Therapies will utilize their expertise in setting apart stem cells to give vital cell types had to study Parkinson's disease. These neural-lineage cell lines will be made use of to further Study intended at the usage of different stem and also progenitor cells as a potential therapy for Parkinson's disease.
"I am quite enthusiastic about this contract with Q Therapies; our Study will benefit from this collaboration in many means," claimed Dollar professor Xianmin Zeng, PhD, who runs both an Institute lab concentrating on embryonic stem cell Study and also the Dollar Institute's CIRM Shared Re"setting apart stem cells is a very engaged process. This contract will aid relocate Parkinson's Study onward in a faster, a lot more effective manner." "We are quite delighted to enter into this collaboration with the Dollar Institute," stated Deborah Eppstein, PhD, Head of state and also CEO of Q. "We look onward to furthering development of cell therapy products to address Parkinson's Diseaseexpertise of both the Dollar Institute and also Q Therapies."
We take the time to listen, to provide you the best care !
About the Dollar Institute
The Dollar Institute is an independent charitable organization dedicated to extending the wellness period, the healthy years of each individual's life. The National Institute of Aging designated the Dollar a Nathan Shock Center of Quality in the Biology of Aging, among simply 5 centers in the nation. Dollar Institute scientists work in an innovative, interdisciplinary setting to understand the mechanisms of Aging and also to discover new means of sensing, stopping and also managing age-related illness such as Alzheimer's and also Parkinson's disease, cancer cells, movement, and also joint inflammation. Joint Study at the Institute is supportedand bioinformatics technology.
About Q Therapies
Q Therapies, Inc. is an emerging biopharmaceutical firm, venture-backed and also privately held, situated in Salt Lake City, Utah. The firm has unique civil liberties to 16 patents developing out of job,, at the College of Utah and also NIH, and also is creating products to address incapacitating illness of the main nerves. The firm's initial product, Q-Cells®& reg;, is a cell-based therapeutic planned to replace the shielding myelin on damaged nerve cells and also give trophic assistance, therepreserving normal feature of nerve cells. Q-Cells® & reg; apply to a large range of demyelinating illness, consisting of numerous sclerosis (MS), transverse myelitis, cerebral palsy, spine cable injury and also white concern movement; and also various other neurodegenerative illness such as ALS (Lou Gehrig's disease) and also Parkinson's disease. Medical tests are expected to begin in 2009 in Transverse Myelitis, a quickly disabling, inflammatory demyelinating spine cable injury related to MS. Q's pipeline consists of various other cell products for managing illness consisting of Alzheimer's disease and also peripheral neuropathies.